Developer docs
API playgroundTry for free, no card

Search company profiles

Cellarian

Full company profile

uuid00048tz

Namestring
Cellarian
Legal namestring
Cellarian, Inc.
Websiteurl
cellarian.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Cellarian, Inc. is a privately held Clinical Decision Support Software company that sells a proprietary, rules-based documentation platform — branded as the "Cellarian Engine" (internal name "Vision") — to diagnostic laboratories and adjacent healthcare providers. The platform generates patient-specific, payer-aligned, provider-attested medical necessity documentation and prior authorization narratives for toxicology, molecular, PGX, respiratory pathogen, UTI, STI, women's health, and wound testing, integrating directly with customer LIMS, EHR, LIS, RCM, and middleware systems. The company explicitly differentiates its product from generative AI, positioning the engine as a continuously updated rules platform built by physicians, compliance specialists, and revenue cycle experts to produce audit-defensible documentation without hallucination risk; documentation has been reviewed for legal compliance by McDonald Hopkins (Jane Pine Wood) and used in Medicare TPE and CERT audits without pushback.

The product is composed of two core modules (Medical Necessity Documentation and Prior Authorization Documentation) plus the Opioid Risk Assessment and Stratification Worksheet as a lead-generation/adjunct resource and a referenced CellarianRx product line. Strategic alliances with Validity Diagnostics (sample-integrity/subversion detection for toxicology) and Shadowbox (HIPAA-compliant EHR/billing/payer-portal connectivity) extend Cellarian into a broader revenue-cycle ecosystem. The company is headquartered in Houston, Texas with an executive team of four (Founder/CEO Dr. Michael Sprintz, President & COO Michael C. Lu, CTO Ian Williamson, CMO Cecilie Korst) and reports operating across 39-40 US states with 200,000+ cumulative reports, 148,000+ medical necessity reports, 52,000+ prior authorizations, and an 80-90% client-reported first-pass prior authorization success rate.

Cellarian generates revenue through quote-based SaaS platform subscriptions with multi-year enterprise contracts sold via a sales-led, demo-driven motion (Calendly scheduling and direct sales outreach), supplemented by professional services for revenue recovery and appeals. Pricing is not publicly disclosed; the customer base of approximately 20 visible logos is concentrated in mid-market diagnostic labs, RCM partners (Lighthouse, Lab Revenue Navigator), pain management practices, and substance use treatment providers. The company has raised approximately $2.765M across two 2016-2017 rounds with no subsequent disclosed capital raises, and the cap table is not public.

Short descriptiontext

Cellarian sells a proprietary, rules-based documentation platform that generates patient-specific, payer-aligned medical necessity documentation and prior authorization narratives for diagnostic laboratories, primarily serving mid-market toxicology, molecular, and PGX labs across 39-40 US states.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersConroe, United States
HQ citystring
Conroe
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical necessity documentation, clinical decision support, prior authorization automation, laboratory revenue cycle, payer compliance software
NAICS code1 code
  • Custom Computer Programming Services541511
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical Decision Support Software
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Platform Subscription (implied)
TypeSubscription Recurring
Description

Cellarian sells access to its proprietary documentation and prior authorization platform to diagnostic laboratories. Pricing is quote-based (not publicly disclosed) and tied to volume of reports and prior authorizations generated (e.g., 200,000+ reports, 52,000+ prior authorizations across clients).

cellarian.com
2Revenue Recovery / Appeals Services
TypeProfessional Services
Description

Cellarian helps labs recover denied claims through automated appeals documentation, seamless integration with LISs and RCM tools to pull denied claims continuously, and smart generation of patient- and payer-specific appeal documents.

cellarian.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Others
Pricing details1 tier
1Custom / quote-based enterprise pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is not publicly disclosed; customers must schedule a demo and request a quote.

cellarian.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1CellarianRx
Description

Product line name referenced in Michael Lu's bio ("one of the first clients for the CellarianRx product line"); appears to be a Cellarian-branded product line.

cellarian.com
+1 more record
Core offering1 text field

Cellarian provides a SaaS platform built around a proprietary, rules-based "Cellarian Engine" that automatically generates patient-specific, payer-aligned, provider-attested medical necessity documentation and prior authorizations for diagnostic laboratories. The platform interfaces with customer LIMS, EHR, LIS, RCM, and middleware systems to apply payer-specific documentation rules upstream in the revenue cycle, aiming to prevent denials, clawbacks, and prior authorization rework before claims are submitted.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 200,000+ reports generated to date
+7 more records
Product overview1 text field

Cellarian is a single unified SaaS platform — built around a proprietary "Cellarian Engine" rules-based documentation engine (also internally called "Vision") — that automates clinical documentation upstream in the laboratory revenue cycle. The platform is composed of two tightly integrated core modules, Medical Necessity Documentation and Prior Authorization Documentation, which together generate patient-specific, payer-aligned, provider-attested documentation for toxicology, molecular PCR, respiratory pathogen, UTI, STI, women's health, and wound testing. Around these core modules sit supporting offerings such as the Opioid Risk Assessment and Stratification Worksheet (a downloadable COT risk-assessment resource) and the CellarianRx product line, and the platform is extended through technical partnerships such as the Cellarian + Shadowbox integration (for EHR/billing/payer-portal connectivity) and the Cellarian + Validity Diagnostics alliance (for toxicology sample-integrity/subversion detection). Cellarian interfaces with customer LIMS, EHR, LIS, RCM, and middleware systems; positions itself explicitly as "not AI" but as a rules-driven automation platform battle-tested against thousands of real lab claims.

Product and service4 records
1Cellarian Engine (Cellarian Platform)
CategoryClinical Decision Support Software
Description

The proprietary documentation engine that generates patient-specific, payer-aligned, provider-attested medical necessity documentation for diagnostic laboratories. Built over years by physicians, compliance specialists, and revenue cycle experts, it is continuously refined to meet changing payer requirements and is positioned as a rules-based automation platform that produces audit-defensible documentation without hallucinated content.

2Medical Necessity Documentation
CategoryClinical Decision Support Software
Description

Module that automatically interfaces with LIMS, EHR, or middleware platforms, pulls structured and unstructured clinical data, applies payer-specific medical necessity criteria, and generates patient-specific justification text for toxicology and molecular PCR testing. Produces unique provider summaries with individualized diagnoses, medications, risk levels, days of abstinence, and treatment/monitoring needs.

3Prior Authorization Documentation
CategoryClinical Decision Support Software
Description

Module that identifies when prior authorization is required, applies payer-specific documentation rules, and generates patient-specific medical necessity justification prepared for physician review and signature. Supports toxicology, respiratory pathogen, UTI, STI, women's health, and wound testing. The rules engine updates documentation logic to reflect evolving payer criteria without manual team intervention.

4CellarianRx
CategoryClinical Decision Support Software
Description

Named product line referenced on the About page; the COO's former company was one of its first clients. Limited public detail available beyond the product-line reference.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierFlagship / Core Integration PartnerTypeTechnology or IntegrationAnnounced on2025-10-03
Description

Complementary partnership in which Shadowbox provides HIPAA-compliant connectivity across EHRs, billing platforms, and payer portals, while Cellarian provides patient-specific medical-necessity documentation, prior authorizations, and audit protection. Together they offer lab orders submitted once, routed correctly, and packaged with payer-ready documentation, reportedly reducing payer denials by 20% and increasing net revenue by 14% per Shadowbox.

Strategic tierFlagship / Core Strategic AllianceTypeStrategic or Co-development PartnerAnnounced on2025-09-15
Description

Strategic alliance pairing Cellarian's medical-necessity documentation with Validity Diagnostics' subversion detection reagents and products. Together they offer a closed-loop compliance ecosystem for toxicology testing that addresses documentation integrity and sample integrity (synthetic urine, tampering, substitution), reducing audit and legal risk.

Strategic tierAdvisory / Legal Review RelationshipTypeImplementation/ SI/ Consulting Partner
Description

Law firm that reviewed Cellarian's documentation for legal compliance. Cellarian's documentation has been used by clients in Medicare TPE and CERT audits without pushback. Cellarian offers to jump on calls with clients' compliance or legal counsel.

4Lighthouse RCM Solutions (Lighthouse Lab Services)
Strategic tierContent / Co-Marketing PartnerTypeGTM or Marketing Partner
Description

Lighthouse team members (e.g., Liset Sanchez) contribute authored content to Cellarian's blog on key billing considerations for toxicology labs. Lighthouse is also displayed as a partner logo on Cellarian's website, indicating a content/GTM alliance.

cellarian.com
5Mark Cleveland / Parallel Entrepreneur Podcast
Strategic tierMinor / Awareness PartnershipTypeGTM or Marketing Partner
Description

CEO Dr. Michael Sprintz appeared as a guest on the "Parallel Entrepreneur" podcast hosted by Mark Cleveland, with the episode promoted via Cellarian's blog.

cellarian.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

End-to-end revenue cycle management platform with prior authorization, eligibility, and denials management for health systems and ambulatory providers. Competes for the same documentation-driven revenue protection wallet share as Cellarian.

TypeBroad incumbent
Description

Large-scale revenue cycle management provider focused on hospital and health-system customers. Overlaps with Cellarian's denials and documentation-driven revenue protection use cases, though it is service-heavy rather than rules-engine SaaS.

TypeBroad incumbent
Description

Speech-to-text and computer-assisted clinical documentation used by hospitals and large physician groups. Adjacent to Cellarian's clinical documentation automation but oriented to broader physician reporting rather than payer-aligned lab justification.

TypeEmerging player
Description

Healthcare automation platform historically focused on revenue cycle workflows including prior authorization and eligibility. Competes in the same payer-rule automation category as Cellarian, though it has been undergoing strategic retrenchment.

TypeBroad incumbent
Description

Healthcare revenue cycle management suite including eligibility verification, claims management, and prior authorization. Competes for the same lab and health-system budget as Cellarian, though it is not lab-specialized.

TypeDirect peer
Description

Provides prior authorization, eligibility, and revenue cycle automation for diagnostic laboratories, radiology groups, and specialty practices. Closely overlaps Cellarian's prior authorization and payer-rule automation value proposition for labs and ambulatory providers.

TypeEmerging player
Description

AI-driven prior authorization and revenue cycle automation for health systems. Tackles the same payer-rule and documentation bottleneck Cellarian addresses, with greater scale ambitions and a more generalist AI orientation.

TypeBroad incumbent
Description

Industry-leading prior authorization automation platform for medications, now extending into clinical and payer workflows. Overlaps with Cellarian's prior authorization automation and payer-rule engine but at a much broader therapeutic and channel footprint.

TypeEmerging player
Description

Patient intake, clinical workflow, and prior authorization automation platform for ambulatory providers and health systems. Addresses adjacent documentation and workflow gaps that touch the same payer-submission lifecycle as Cellarian.

TypeBroad incumbent
Description

Cloud-based revenue cycle management platform that automates prior authorization, claims management, and denials for hospitals and labs. Addresses the same documentation/denial pain points as Cellarian but at a much larger, broader portfolio scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers19 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cellarian

Clinical Decision Support Softwarecellarian.com

Cellarian sells a proprietary, rules-based documentation platform that generates patient-specific, payer-aligned medical necessity documentation and prior authorization narratives for diagnostic laboratories, primarily serving mid-market toxicology, molecular, and PGX labs across 39-40 US states.

What Cellarian does

Cellarian, Inc. is a privately held Clinical Decision Support Software company that sells a proprietary, rules-based documentation platform — branded as the "Cellarian Engine" (internal name "Vision") — to diagnostic laboratories and adjacent healthcare providers. The platform generates patient-specific, payer-aligned, provider-attested medical necessity documentation and prior authorization narratives for toxicology, molecular, PGX, respiratory pathogen, UTI, STI, women's health, and wound testing, integrating directly with customer LIMS, EHR, LIS, RCM, and middleware systems. The company explicitly differentiates its product from generative AI, positioning the engine as a continuously updated rules platform built by physicians, compliance specialists, and revenue cycle experts to produce audit-defensible documentation without hallucination risk; documentation has been reviewed for legal compliance by McDonald Hopkins (Jane Pine Wood) and used in Medicare TPE and CERT audits without pushback.

The product is composed of two core modules (Medical Necessity Documentation and Prior Authorization Documentation) plus the Opioid Risk Assessment and Stratification Worksheet as a lead-generation/adjunct resource and a referenced CellarianRx product line. Strategic alliances with Validity Diagnostics (sample-integrity/subversion detection for toxicology) and Shadowbox (HIPAA-compliant EHR/billing/payer-portal connectivity) extend Cellarian into a broader revenue-cycle ecosystem. The company is headquartered in Houston, Texas with an executive team of four (Founder/CEO Dr. Michael Sprintz, President & COO Michael C. Lu, CTO Ian Williamson, CMO Cecilie Korst) and reports operating across 39-40 US states with 200,000+ cumulative reports, 148,000+ medical necessity reports, 52,000+ prior authorizations, and an 80-90% client-reported first-pass prior authorization success rate.

Cellarian generates revenue through quote-based SaaS platform subscriptions with multi-year enterprise contracts sold via a sales-led, demo-driven motion (Calendly scheduling and direct sales outreach), supplemented by professional services for revenue recovery and appeals. Pricing is not publicly disclosed; the customer base of approximately 20 visible logos is concentrated in mid-market diagnostic labs, RCM partners (Lighthouse, Lab Revenue Navigator), pain management practices, and substance use treatment providers. The company has raised approximately $2.765M across two 2016-2017 rounds with no subsequent disclosed capital raises, and the cap table is not public.

Cellarian firmographics

Firmographics
Name
Cellarian
Legal name
Cellarian, Inc.
Website
https://cellarian.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
Cellarian sells a proprietary, rules-based documentation platform that generates patient-specific, payer-aligned medical necessity documentation and prior authorization narratives for diagnostic laboratories, primarily serving mid-market toxicology, molecular, and PGX labs across 39-40 US states.
Ownership category
akta.pro rank

Where Cellarian is headquartered

Location

Headquarters

HQ city
Conroe
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cellarian business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Others

Revenue model

  1. SaaS Platform Subscription (implied): Cellarian sells access to its proprietary documentation and prior authorization platform to diagnostic laboratories. Pricing is quote-based (not publicly disclosed) and tied to volume of reports and prior authorizations generated (e.g., 200,000+ reports, 52,000+ prior authorizations across clients).
  2. Revenue Recovery / Appeals Services: Cellarian helps labs recover denied claims through automated appeals documentation, seamless integration with LISs and RCM tools to pull denied claims continuously, and smart generation of patient- and payer-specific appeal documents.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom / quote-based enterprise pricing

Go-to-market motion3 records

Distribution channels2 records

Marketing channels7 records

Cellarian product offering

Product offering

Core offering

Cellarian provides a SaaS platform built around a proprietary, rules-based "Cellarian Engine" that automatically generates patient-specific, payer-aligned, provider-attested medical necessity documentation and prior authorizations for diagnostic laboratories. The platform interfaces with customer LIMS, EHR, LIS, RCM, and middleware systems to apply payer-specific documentation rules upstream in the revenue cycle, aiming to prevent denials, clawbacks, and prior authorization rework before claims are submitted.

Product overview

Cellarian is a single unified SaaS platform — built around a proprietary "Cellarian Engine" rules-based documentation engine (also internally called "Vision") — that automates clinical documentation upstream in the laboratory revenue cycle. The platform is composed of two tightly integrated core modules, Medical Necessity Documentation and Prior Authorization Documentation, which together generate patient-specific, payer-aligned, provider-attested documentation for toxicology, molecular PCR, respiratory pathogen, UTI, STI, women's health, and wound testing. Around these core modules sit supporting offerings such as the Opioid Risk Assessment and Stratification Worksheet (a downloadable COT risk-assessment resource) and the CellarianRx product line, and the platform is extended through technical partnerships such as the Cellarian + Shadowbox integration (for EHR/billing/payer-portal connectivity) and the Cellarian + Validity Diagnostics alliance (for toxicology sample-integrity/subversion detection). Cellarian interfaces with customer LIMS, EHR, LIS, RCM, and middleware systems; positions itself explicitly as "not AI" but as a rules-driven automation platform battle-tested against thousands of real lab claims.

Differentiator

Problem solved

Functional benefit

Brands

  • CellarianRx: Product line name referenced in Michael Lu's bio ("one of the first clients for the CellarianRx product line"); appears to be a Cellarian-branded product line.
  • Vision

Products and services

  • Cellarian Engine (Cellarian Platform) The proprietary documentation engine that generates patient-specific, payer-aligned, provider-attested medical necessity documentation for diagnostic laboratories. Built over years by physicians, compliance specialists, and revenue cycle experts, it is continuously refined to meet changing payer requirements and is positioned as a rules-based automation platform that produces audit-defensible documentation without hallucinated content.
  • Medical Necessity Documentation Module that automatically interfaces with LIMS, EHR, or middleware platforms, pulls structured and unstructured clinical data, applies payer-specific medical necessity criteria, and generates patient-specific justification text for toxicology and molecular PCR testing. Produces unique provider summaries with individualized diagnoses, medications, risk levels, days of abstinence, and treatment/monitoring needs.
  • Prior Authorization Documentation Module that identifies when prior authorization is required, applies payer-specific documentation rules, and generates patient-specific medical necessity justification prepared for physician review and signature. Supports toxicology, respiratory pathogen, UTI, STI, women's health, and wound testing. The rules engine updates documentation logic to reflect evolving payer criteria without manual team intervention.
  • CellarianRx Named product line referenced on the About page; the COO's former company was one of its first clients. Limited public detail available beyond the product-line reference.

Quantifiable outcome

  • 200,000+ reports generated to date
  • +7 more outcomes

Companies that use Cellarian

Customer profile

Named customers19 records

Segments5 records

Ideal customer profiles5 records

Cellarian technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature5 records

Cellarian partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered flagship / core integration partner, flagship / core strategic alliance, advisory / legal review relationship, content / co-marketing partner and minor / awareness partnership.

  • Shadowboxflagship / core integration partnerTechnology or Integration · 3 October 2025Complementary partnership in which Shadowbox provides HIPAA-compliant connectivity across EHRs, billing platforms, and payer portals, while Cellarian provides patient-specific medical-necessity documentation, prior authorizations, and audit protection. Together they offer lab orders submitted once, routed correctly, and packaged with payer-ready documentation, reportedly reducing payer denials by 20% and increasing net revenue by 14% per Shadowbox.
  • Validity Diagnosticsflagship / core strategic allianceStrategic or Co-development Partner · 15 September 2025Strategic alliance pairing Cellarian's medical-necessity documentation with Validity Diagnostics' subversion detection reagents and products. Together they offer a closed-loop compliance ecosystem for toxicology testing that addresses documentation integrity and sample integrity (synthetic urine, tampering, substitution), reducing audit and legal risk.
  • McDonald Hopkins (Jane Pine Wood)advisory / legal review relationshipImplementation/ SI/ Consulting PartnerLaw firm that reviewed Cellarian's documentation for legal compliance. Cellarian's documentation has been used by clients in Medicare TPE and CERT audits without pushback. Cellarian offers to jump on calls with clients' compliance or legal counsel.
  • Lighthouse RCM Solutions (Lighthouse Lab Services)content / co-marketing partnerGTM or Marketing PartnerLighthouse team members (e.g., Liset Sanchez) contribute authored content to Cellarian's blog on key billing considerations for toxicology labs. Lighthouse is also displayed as a partner logo on Cellarian's website, indicating a content/GTM alliance.
  • Mark Cleveland / Parallel Entrepreneur Podcastminor / awareness partnershipGTM or Marketing PartnerCEO Dr. Michael Sprintz appeared as a guest on the "Parallel Entrepreneur" podcast hosted by Mark Cleveland, with the episode promoted via Cellarian's blog.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Cellarian competitors and assessment

Company assessment

Broad incumbents

  • FinThrive: End-to-end revenue cycle management platform with prior authorization, eligibility, and denials management for health systems and ambulatory providers. Competes for the same documentation-driven revenue protection wallet share as Cellarian.
  • R1 RCM: Large-scale revenue cycle management provider focused on hospital and health-system customers. Overlaps with Cellarian's denials and documentation-driven revenue protection use cases, though it is service-heavy rather than rules-engine SaaS.
  • M*Modal (3M Health Information Systems): Speech-to-text and computer-assisted clinical documentation used by hospitals and large physician groups. Adjacent to Cellarian's clinical documentation automation but oriented to broader physician reporting rather than payer-aligned lab justification.
  • Experian Health: Healthcare revenue cycle management suite including eligibility verification, claims management, and prior authorization. Competes for the same lab and health-system budget as Cellarian, though it is not lab-specialized.
  • CoverMyMeds (McKesson): Industry-leading prior authorization automation platform for medications, now extending into clinical and payer workflows. Overlaps with Cellarian's prior authorization automation and payer-rule engine but at a much broader therapeutic and channel footprint.
  • Waystar: Cloud-based revenue cycle management platform that automates prior authorization, claims management, and denials for hospitals and labs. Addresses the same documentation/denial pain points as Cellarian but at a much larger, broader portfolio scale.

Emerging players

  • Olive AI: Healthcare automation platform historically focused on revenue cycle workflows including prior authorization and eligibility. Competes in the same payer-rule automation category as Cellarian, though it has been undergoing strategic retrenchment.
  • AKASA: AI-driven prior authorization and revenue cycle automation for health systems. Tackles the same payer-rule and documentation bottleneck Cellarian addresses, with greater scale ambitions and a more generalist AI orientation.
  • Phreesia: Patient intake, clinical workflow, and prior authorization automation platform for ambulatory providers and health systems. Addresses adjacent documentation and workflow gaps that touch the same payer-submission lifecycle as Cellarian.

Direct peers

  • Infinx Healthcare: Provides prior authorization, eligibility, and revenue cycle automation for diagnostic laboratories, radiology groups, and specialty practices. Closely overlaps Cellarian's prior authorization and payer-rule automation value proposition for labs and ambulatory providers.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights6 records

Customer concentration

Cellarian social profiles

Digital presence

Cellarian compliance and trust

Trust signal

Compliance1 record

Cellarian financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cellarian leadership team

Management profile

Number of profiles

Profiles4 records

Cellarian funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cellarian M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cellarian

What does Cellarian do?

Cellarian provides a SaaS platform built around a proprietary, rules-based "Cellarian Engine" that automatically generates patient-specific, payer-aligned, provider-attested medical necessity documentation and prior authorizations for diagnostic laboratories. The platform interfaces with customer LIMS, EHR, LIS, RCM, and middleware systems to apply payer-specific documentation rules upstream in the revenue cycle, aiming to prevent denials, clawbacks, and prior authorization rework before claims are submitted.

Is Cellarian a public or private company?

Cellarian is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Cellarian founded?

Cellarian was founded in 2024. It employs 1 to 10 people.

Where is Cellarian based?

Cellarian is headquartered in Conroe, United States, in the North America region.

How does Cellarian make money?

Two revenue lines are on record. SaaS Platform Subscription (implied) is the primary driver. The others are revenue Recovery / Appeals Services.

Who are Cellarian's main competitors?

Broad incumbents on record are FinThrive, R1 RCM, M*Modal (3M Health Information Systems), Experian Health, CoverMyMeds (McKesson) and Waystar. Emerging players are Olive AI, AKASA and Phreesia. Infinx Healthcare is listed as a direct peer.

Does Cellarian have an API?

No public API is recorded for Cellarian.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales